Oxygen therapy is widely used to treat a variety of chronic and acute health conditions. The therapy can be used in a hospital or pre-hospital setting (for instance, in an ambulance) to manage emergency situations or it can be used at home to manage long-term health conditions.

Data Bridge Market Research analyses that the oxygen therapy market which was USD 33.47 billion in 2021, would rocket up to USD 74.02 billion by 2029, and is expected to undergo a CAGR of 10.43% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

View Detailed Report@ https://www.databridgemarketresearch.com/reports/global-oxygen-ther...

Recent developments

In November 2021, UNICEF partnered with the UK government and Oxygen CoLab to create a powerful oxygen concentrator for use in low-resource settings. This progress is being made as part of an initiative to combat the coronavirus crisis and meet the demand for oxygen in critical care settings. The increased competition in the industry can be attributed to the growing number of players, frequent product approvals, and effective distribution agreements.
Drivers

Technological advancements
The introduction of technologically advanced oxygen source and delivery devices that provide efficient patient care is expected to boost industry growth. Among these advancements are flow regulating devices, sensors, and the integration of delivery devices and pulse dose metres. O2 therapy is becoming more popular due to the potential benefits such as controlled flow, efficient dosing, faster response rates, and greater durability and reliability. The above mentioned factors are expected to drive industry growth.

Rising popularity of portable oxygen concentrators
Rising popularity and adoption of on-demand and continuous portable oxygen concentrators (POC) in a variety of applications such as emergency medicine will also fuel demand in the coming years. This increase is attributed to the entry of global competitors into the market, consumer demand for portable technology and the clinical urgency for greater mobility support for the geriatric population. The business is expected to grow as a result of continuous innovation, which results in more efficient units and lower prices.

Some of the major players operating in the oxygen therapy market are:

General Electric (U.S.)
Tecno-Gaz S.p.A (Italy)
HERSILL (Spain)
Koninklijke Philips N.V. (Netherlands)
DeVilbiss Healthcare LLC (U.S.)
Smiths Group plc. (U.K.)
Allied Healthcare Products, Inc. (U.S.)
Teleflex Incorporated (U.S.)
Invacare Corporation (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Essex Industries, Inc. (U.S.)
OxyBand Technologies (U.S.)
Nidek Medical Products, Inc (U.S.)
About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- [email protected]